Terminated PHASE1 INTERVENTIONAL 2-arm NCT02486744

Safety and Efficacy of Acthar Gel in an Outpatient Dialysis Population

Sponsor: Youngstown State University

Interventions Acthar Gel

Updated 6 times since 2017 Last updated: Feb 8, 2017 Started: Mar 31, 2015 Primary completion: Jul 31, 2016 Completion: Jul 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Recruitment challenges and unforseen costs to continue

Other End Stage Renal Disease trials with similar outcome

Browse all End Stage Renal Disease trials

Listed as NCT02486744, this PHASE1 trial focuses on End Stage Renal Disease and remains terminated or withdrawn. Sponsored by Youngstown State University, it has been updated 6 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE1
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE1
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE1
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE1
Feb 2017 — Jun 2018 [monthly]

Terminated PHASE1

Status: Recruiting → Terminated · Phase: NA → PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Recruiting NA

First recorded

Mar 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Youngstown State University

Data source: Youngstown State University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Canfield, United States